Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Capital Hilton

28 oct 2024 8:30 a.m. - 30 oct 2024 12:40 p.m.

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Session 1: Keynote Address

Session Chair(s)

Jeffrey  Foy, PhD

Jeffrey Foy, PhD

Senior VP, Toxicology

PepGen Inc., United States

Session 1: Keynote Address

Speaker(s)

Peter P. Stein, MD

Speaker

Peter P. Stein, MD

FDA, United States

Director, Office of New Drugs, CDER

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.